Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Not More Conservative Than EU, Jenkins Says; Investors Not Convinced

Executive Summary

Perceptions that FDA is more conservative in its approval standards than its European regulatory counterpart are misguided and largely overblown, Office of New Drugs Director John Jenkins said
Advertisement

Related Content

FDA, EMA Confidentiality Agreement Expanding Into "Clusters"
FDA, EMA Confidentiality Agreement Expanding Into "Clusters"
"Lagging Indicators": Is There A "Drug Lag" Between U.S. And Europe?
"Lagging Indicators": Is There A "Drug Lag" Between U.S. And Europe?
Pfizer Thelin development (correction)
Pfizer Thelin development (correction)
Sanofi’s Rimonabant Off The European Market; CHMP Finds Risk Management Plan Does Not Adequately Address Depression
Schering Plough’s Bridion Faces FDA Setback
“Fixer-Upper” Encysive’s Thelin Is Pfizer’s Problem Now
Sanofi Withdraws Zimulti NDA For Weight Loss

Topics

Advertisement
UsernamePublicRestriction

Register

PS050502

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel